Parexel International Corporation

Parexel International Corporation is a prominent global Contract Research Organization (CRO) established in 1982 by Josef von Rickenbach and Anne B. Sayigh. Headquartered in Raleigh, North Carolina, Parexel is recognized for delivering comprehensive clinical research and consulting services to the pharmaceutical, biotechnology, and medical device industries.

With approximately 24,000 employees as of 2025, Parexel operates over 84 facilities across more than 51 countries, including a significant presence in Miami. The company combines patient-centric approaches and innovative technologies to support clinical trials worldwide.

When Was Parexel International Corporation Established?

Founded: 1982
Founders: Josef von Rickenbach and Anne B. Sayigh
Headquarters: Raleigh, North Carolina, USA
Industry: Contract Research Organization (CRO)
Global Facilities: Over 84 facilities in 51+ countries
Employees: Approximately 24,000 (as of 2025)
Annual Revenue: Approximately $2.3 billion (as of 2017)

Parexel’s Mission Statement

"To design and deliver clinical trials with patients in mind, broadening access and making clinical research a care option for anyone, anywhere."

What Is Parexel International Corporation Known For?

Parexel International Corporation is widely recognized for its patient-centric approach and comprehensive suite of clinical research and consulting services tailored to the pharmaceutical, biotech, and medical device sectors.

Comprehensive Clinical Trial Management

Parexel offers extensive clinical trial management services, including data management, medical writing, biostatistics, and pharmacovigilance. Its broad expertise ensures quality and compliance at every stage of drug development.

Innovative Technology Integration

Committed to innovation, Parexel partnered with Palantir Technologies in 2024 to utilize artificial intelligence for enhancing data management and clinical study design, setting new standards in CRO services.

Global Patient-Centric Approach

Emphasizing patient-centricity, Parexel integrates deep local knowledge with global expertise to broaden access to clinical trials, making research a care option accessible worldwide.

How Extensive Is Parexel’s Global Presence?

Parexel operates in over 84 facilities across more than 51 countries, maintaining a significant presence in North America—including Miami—and expanding rapidly in emerging markets.

The company plans to grow its workforce in India by over 2,000 in the coming three to five years, positioning itself as a major player in early-stage clinical trial operations.

Which Locations Does Parexel Operate In?

Parexel is headquartered in Raleigh, North Carolina, with substantial operations throughout the United States, including Miami. Its international footprint spans Europe, Asia, and other key global markets to serve biopharmaceutical clients worldwide.

Who Owns Parexel International Corporation?

Parexel is a leading independent Contract Research Organization competing with major CRO companies like IQVIA, Syneos Health, and ICON. It distinguishes itself through patient-centric services and advanced technology-driven solutions, operating as a private enterprise with a strong global workforce.

Is Parexel Currently Hiring?

You can check out the open positions that Parexel International Corporation has right here on OysterLink.